Inadequate treatment with HMG-CoA reductase inhibitors by health care providers-Reference-Cited by-同舟云学术

Inadequate treatment with HMG-CoA reductase inhibitors by health care providers

Published:1996-06 Issue:6 Volume:100 Page:605-610
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Marcelino Jennifer J.,Feingold Kenneth R.

Publisher

Elsevier BV

Subject

General Medicine

Reference20 articles.

1. Incidence of coronary heart disease and lipoprotein cholesterol levels.The Framingham study;Castelli;JAMA,1986

2. Serum Cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial;Neaton;Arch Intern Med,1992

3. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms;Levine;NEJM,1995

4. Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management;Superko;Circulation,1994

5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical inertia in lipid screening and prescribing statins for primary prevention: Experience from a low-to-middle income country;International Journal of Noncommunicable Diseases;2021

2. Utilization of High-Intensity Statins in Patients at Risk for Cardiovascular Events: A National Cross-Sectional Study;American Journal of Therapeutics;2020-10-01

3. Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial;Stroke;2020-10

4. The Development of a Clinical Decision Support System for the Management of Pediatric Food Allergy;Clinical Pediatrics;2016-10-26

5. Lipid-lowering treatment in patients at high cardiovascular risk discharged from an Italian hospital;Journal of Cardiovascular Medicine;2013-04